Skip to main content

Day: April 28, 2020

The Rise of E-Money Across the Philippines

Manila, April 2020 – ​The Philippines is transforming its financial services with the target to have 20% of transactions done electronically by 2020. However, despite the rapidly expanding financial technology, 99% of current local transactions are still made in cash. With the support from both private and government institutions, e-money will continue to drive the industry forward and change the payment landscape in the country, as highlighted in our latest report, ​“​The Digitization of the Philippine Wallet: E-Money’s Emergence in the Philippines​”​. The Impressive Growth of E-MoneyE-money has seen a steady growth from 2014 to 2018, with 8% and 15% CAGR in amount inflows and amount usage respectively. Transaction numbers are also seeing steep growth rates, with usage boasting a 36% CAGR throughout the same period. With...

Continue reading

Sanofi: Annual General Meeting of April 28, 2020

Annual General Meeting of April 28, 2020Approval of the financial statements for the fiscal year 2019Dividend of €3.15 per share payable as of May 6, 2020Board composition: renewals, ratification of a co-opting Director and appointment of two new Independent DirectorsParis, France – April 28, 2020 –  The Ordinary General Shareholders’ Meeting of Sanofi was held on April 28, 2020, without the physical presence of its shareholders, in accordance with the derogating measures adapting the rules governing the deliberation of general meetings taken by the French authorities as part of the fight against COVID-19, at the Company’s registered office in Paris, under the chairmanship of Serge Weinberg.All resolutions submitted to the vote were adopted by the shareholders, except for the nineteenth resolution relating to the compensation awarded...

Continue reading

Sanofi: Assemblée Générale Annuelle du 28 avril 2020

Assemblée Générale Annuelle du 28 avril 2020Approbation des comptes sociaux et des comptes consolidés de l’exercice 2019Dividende de 3,15 euros par action qui sera mis en paiement à compter du 6 mai 2020Composition du Conseil d’administration : renouvellements, ratification d’une cooptation et nomination de deux nouveaux administrateurs indépendantsParis, France – Le 28 avril 2020 – L’Assemblée Générale Ordinaire des actionnaires de Sanofi s’est réunie le 28 avril 2020 à huis clos, conformément aux mesures dérogatoires portant adaptation des règles de réunion et de délibération des assemblées prises par les autorités françaises dans le cadre de la lutte contre le Covid-19, au siège social de la Société à Paris, sous la présidence de Serge Weinberg.Toutes les résolutions soumises au vote ont été adoptées par ses actionnaires,...

Continue reading

Resilient Adjusted EBITDA in Q1 2020 in spite of slightly lower revenues – Strong focus on costs reduction and cash preservation in the wake of the Covid-19 crisis

First Quarter 2020 ResultsNet revenues down -2.2% with a like-for-like change of -2.9% versus Q1 2019Q1 2020 activity impacted by lockdown measures at the end of the quarter, particularly in Europe; demand impacted in all key regions since early AprilAdjusted EBITDA of €42.4 million or a 6.9% margin, stable versus last yearMaintained profitability year-on-year thanks to solid achievements in cost reduction and some easing of raw material costsSubstantial additional set of cost cutting measures to adapt to reduced demand in Q2 2020 and strict cash management to protect cash-flowsSolid level of liquidity with €650 million in cash and confirmed credit lines at the end of March; ongoing discussion with banks to set up additional credit lines and waive financial covenantAdjusted EBITDA to be affected in Q2 and FY 2020 by the current situation,...

Continue reading

Résilience de l’EBITDA ajusté au premier trimestre malgré une légère baisse du chiffre d’affaires – Focalisation sur la réduction de coûts et la préservation de la liquidité dans le contexte de la crise du Covid-19

Résultats du 1er trimestre 2020Chiffre d’affaires en baisse de -2,2%, et de -2,9% à taux de change et périmètre comparables par rapport au T1 2019Activité du T1 2020 affectée par les mesures de confinement mises en place à la fin du trimestre, tout particulièrement en Europe ; demande pénalisée dans toutes les régions à partir de début avrilEBITDA ajusté de 42,4 millions d’euros, soit une marge de 6,9%, stable par rapport au T1 2019Rentabilité maintenue par rapport à l’année dernière grâce à un bon niveau de réduction des coûts et à un allègement du coût des matières premièresMise en œuvre de mesures fortes afin de réduire les coûts pour s’adapter à la baisse de la demande prévue sur le T2 2020 et protéger les flux de trésorerieLiquidité solide avec une trésorerie et des lignes de crédit confirmées pour plus de 650 millions d’euros à...

Continue reading

Exel Industries :Q2 2019-2020 sales Mixed impact of the health crisis depending on activity

PRESS RELEASE                                                                                                             April 28, 2020Q2 2019-2020 salesMixed impact of the health crisis depending on activity(*) The amounts at constant scope and foreign exchange rates are calculated:– by converting the amounts for the current quarter at the average quarterly exchange rates of the previous year;– by excluding Intec sales, a company acquired in February 2020.Q2 2019-2020 sales (January to March 2020) totaled €194.9 million, down 10.1% on Q2 2018-2019.This decrease is predominantly attributable to the Agricultural Spraying and Garden Watering and Spraying activities, which were impacted by the Covid-19 crisis just as their season got underway.·Agricultural SprayingAfter a stable first quarter compared with last year, the decrease...

Continue reading

EXEL INDUSTRIES :Chiffre d’affaires 2ème trimestre 2019-2020 Impact de la crise sanitaire contrasté selon les activités

COMMUNIQUE DE PRESSE                                                                                       Le 28 avril 2020Chiffre d’affaires 2ème trimestre 2019-2020Impact de la crise sanitaire contrasté selon les activités(*) Les montants à taux de change et périmètre constants sont calculés :–  en convertissant les montants du trimestre en cours aux taux de change moyens trimestriels de l’année précédente ;– en excluant le chiffre d’affaires d’Intec, société acquise en février 2020.Le chiffre d’affaires du deuxième trimestre de l’exercice 2019-2020 (janvier à mars 2020) s’élève à 194,9M€, en recul de 10,1% par rapport au 2ème trimestre 2018-2019.La baisse provient principalement des activités Pulvérisation Agricole et Arrosage et pulvérisation du jardin, impactées par la crise Covid-19 alors que leur saison commence.·Pulvérisation...

Continue reading

Fleury Michon : Communiqué de mise à disposition du Document d’enregistrement universel 2019

FLEURY MICHONCOMMUNIQUÉ DE MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2019Pouzauges –  le 28 avril 2020 après bourseLa société Fleury Michon a déposé le 28 avril 2020 auprès de l’Autorité des Marchés Financiers (AMF) le Document d’enregistrement universel 2019.Ce document est disponible, en version française, sur le site internet www.fleurymichon.fr rubrique Groupe/finance/documents 2019/Rapports et également sur le site de l’AMF www.amf-france.org.Le Document d’enregistrement universel inclut notamment :Le rapport financier annuel 2019 ;Les rapports des Commissaires aux comptes et les informations relatives à leurs honoraires ;Le rapport sur le gouvernement d’entreprise ;Le descriptif du programme de rachat d’actions propres ;La Déclaration de Performance extra-financière.Contact communauté financière : Philippe Teisseire,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.